This updated Medicines Q & A reviews the evidence available and considers when prophylactic doses of low molecular weight heparins can be used in patients…
A UKMi Product Safety assessment on Zalviso® (sufentanil citrate) sublingual tablets which describes the in-use medication safety considerations resultant from the product’s presentation or other…
On the basis of biblical statements, Jehovah’s Witnesses decline the transfusion of whole blood, red cells, white cells, plasma and platelets. This Medicines Q&A discusses…
Esmya (ulipristal acetate 5mg tablets) was launched in April 2012 for pre-operative treatment of moderate to severe symptoms of uterine fibroids in women of reproductive…
Based on the pharmacokinetics and pharmacodynamics of individual herbal medicines the recommendations for discontinuation vary between 24 hours and 2 weeks. It is generally advised…
Bariatric surgery may impact on the absorption and side effect profile of some medicines. Although this is a growing area, primary information in the field…